A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 51,090 shares of BLCO stock, worth $741,826. This represents 0.01% of its overall portfolio holdings.

Number of Shares
51,090
Previous 56,090 8.91%
Holding current value
$741,826
Previous $950,000 7.05%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$13.68 - $17.6 $68,400 - $88,000
-5,000 Reduced 8.91%
51,090 $883,000
Q2 2023

Aug 10, 2023

BUY
$16.03 - $20.07 $1,603 - $2,007
100 Added 0.18%
56,090 $1.13 Million
Q1 2023

May 12, 2023

BUY
$15.67 - $18.91 $159,834 - $192,882
10,200 Added 22.28%
55,990 $974,000
Q4 2022

Feb 13, 2023

BUY
$13.66 - $16.04 $8,196 - $9,624
600 Added 1.33%
45,790 $710,000
Q3 2022

Nov 10, 2022

BUY
$14.23 - $17.76 $643,053 - $802,574
45,190 New
45,190 $961,000

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $5.08B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.